SOURCE PRECISION MEDICINE, INC.
Space-grade silicon solar modules and arrays for satellites
- Sector
- Materials
- Headquarters
- BOUNDER, CO
- Latest Form D
- $500K, Aug 2010
- Total capital
- $2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $2M
- 2 Form D · last Aug 2010
- 194 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 12 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$500K
- Private capital raisedForm D · SEC · 1st filing$1.5M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- J. Terence CarletonDirectorNamed in SEC Form D filings
- Karl WassmanExecutive Officer, DirectorNamed in SEC Form D filings
- Karl WassmannExecutive Officer, DirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 12- PendingGene Expression Profiling For Predicting The Response To Immunotherapy And/or The Survivability Of Melanoma SubjectsUSPTOApplication PCTUS2011038891
- PendingGene Expression Profiling For Predicting The Survivability Of Prostate Cancer SubjectsUSPTOApplication PCTUS2009049935
- PendingGene Expression Profiling For Identification, Monitoring, And Treatment Of OsteoarthritisUSPTOApplication PCTUS2009048684
Show all 12 patent records
- Gene Expression Profiling For Predicting The Response To Immunotherapy And/or The Survivability Of Melanoma SubjectsApplication PCTUS2011038891Pending
- Gene Expression Profiling For Predicting The Survivability Of Prostate Cancer SubjectsApplication PCTUS2009049935Pending
- Gene Expression Profiling For Identification, Monitoring, And Treatment Of OsteoarthritisApplication PCTUS2009048684Pending
- Gene Expression Profiling For Identification, Monitoring, And Treatment Of Lupus ErythematosusApplication PCTUS2008001070Pending
- Gene Expression Profiling For Identification, Monitoring, And Treatment Of Ocular DiseaseApplication PCTUS2007025865Pending
- Gene EX9RESSION Profiling For Indentification,monitoring, And Treatment Of Colorectal CancerApplication PCTUS2007023407Pending
- Gene Expression Profiling For Identification, Monitoring, And Treatment Of Breast CancerApplication PCTUS2007023385Pending
- Gene Expression Profiling For Identification, Monitoring, And Treatment Of Cervical CancerApplication PCTUS2007023387Pending
- Gene Expression Profiling For Identification, Monitoring And Treatment Of Ovarian CancerApplication PCTUS2007023384Pending
- Gene Expression Profiling For Identification, Monitoring, And Treatment Of Lung CancerApplication PCTUS2007023406Pending
- Gene Expression Profiling For Identification, Monitoring, And Treatment Of Prostate CancerApplication PCTUS2007023425Pending
- Gene Expression Profiling For Identification Of CancerApplication PCTUS2007023459Pending
Related companies, and why
- Quanta LaboratoriesSimilar federal contract value in Materials · null in contracts
- Haddad Consulting L.L.C.Similar federal contract value in Materials · null in contracts
- RE Shoes, LLCSimilar federal contract value in Materials · null in contracts
- Quick-Med Technologies, InSimilar federal contract value in Materials · null in contracts
- SUMMERDALE, INC.Similar federal contract value in Materials · null in contracts
- RETURN TO VENDOR, COSimilar federal contract value in Materials · null in contracts
Regulatory activity · Materials
- Eliminating Regulations Establishing Fellowships in Laboratory Standardization and Testing for Foreign CitizensNational Institute of Standards and Technology
- Eliminating Obsolete Marking Requirements for Toy, Look-Alike, and Imitation FirearmsNational Institute of Standards and Technology
- Eliminating Obsolete Regulations Related to the Advanced Technology Program and the Technology Innovation ProgramNational Institute of Standards and Technology
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .